Epigenetic control of early neurodegenerative events in diabetic retinopathy by the histone deacetylase SIRT6

E-ISSN： 1471-4159|144|2|128-138

ISSN： 0022-3042

Source： JOURNAL OF NEUROCHEMISTRY (ELECTRONIC), Vol.144, Iss.2, 2018-01, pp. : 128-138

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Marine Actinomycetes as potential source for histone deacetylase inhibitors and epigenetic modulation

LETTERS IN APPLIED MICROBIOLOGY, Vol. 61, Iss. 1, 2015-07 ,pp. : 69-76

John Wiley & Sons Inc

Access to resources Recommend Favorite

Improved Histone Deacetylase Inhibitors as Therapeutics for the Neurodegenerative Disease Friedreich’s Ataxia: A New Synthetic Route

By Xu Chunping Soragni Elisabetta Jacques Vincent Rusche James R. Gottesfeld Joel M.

Pharmaceuticals, Vol. 4, Iss. 12, 2011-12 ,pp. : 1578-1590

MDPI

Access to resources Recommend Favorite

Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression

THE EMBO JOURNAL, Vol. 21, Iss. 11, 2002-06 ,pp. : 2672-2681

John Wiley & Sons Inc

Access to resources Recommend Favorite

Augmentation of Cationic Antimicrobial Peptide Production with Histone Deacetylase Inhibitors as a Novel Epigenetic Therapy for Bacterial Infections

By Yedery Roshan D. Jerse Ann E.

Antibiotics, Vol. 4, Iss. 1, 2015-01 ,pp. : 44-61

MDPI

Access to resources Recommend Favorite

Epigenetic Control and Cancer: The Potential of Histone Demethylases as Therapeutic Targets

By Lizcano Fernando Garcia Jeison

Pharmaceuticals, Vol. 5, Iss. 9, 2012-09 ,pp. : 963-990

MDPI

Access to resources Recommend Favorite